Sign in
4

Changes in Ownership

COLLEGIUM PHARMACEUTICAL, INC Filed Acc 0001062993-25-014766

EVP & Chief Commercial Officer sold 16,389 shares at $38.21 ($626,171)

  • EVP & Chief Commercial Officer acquired 16,389 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Dreyer Scott · EVP & Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-18 Exercise or conversion : show line 1 in the form 10b5-1 +16,389 $21.34 $349,741 120,002 D
2025-08-18 Sale : show line 2 in the form 10b5-1 −16,389 $38.21 $626,171 103,613 D
Open-market sales · 16,389 sh · avg $38.21 · $626,171

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-18 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Purchase) −16,389 0 D
Loading xslF345X05/form4.xml…